Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Johanna Kremer Hovinga"'
Autor:
Johanna KREMER HOVINGA, Javier DE LA RUBIA, Katerina PAVENSKI, Ara METJIAN, Paul KNÖBL, Flora PEYVANDI, Spero CATALAND, Paul COPPO, Umer KHAN, Laurel A. MENAPACE, Ana PAULA MARQUES, Sriya GUNAWARDENA, Marie SCULLY
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S16- (2023)
Objective: The management of exacerbations and disease relapse is important for patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP). Severe ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member
Externí odkaz:
https://doaj.org/article/8430c5d0288e4d8493923421ee25e347
Autor:
Paul Coppo, Marie Scully, Johanna Kremer Hovinga, Erika Tarasco, Rosa Willock, Maria Jose Aragon, Parth Patwari, Linda T. Wang, Michael Cronin, Björn Mellgård, Olulade Ayodele, Ping Du
Publikováno v:
HemaSphere, Vol 7, p e399225d (2023)
Externí odkaz:
https://doaj.org/article/6f131dc016ef47aaae3c23bd759b6fe9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johanna Kremer Hovinga
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum. 16
Autor:
Johanna Kremer Hovinga
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 16
Autor:
Johanna Kremer-Hovinga, Maurice Redondo, Bernd R. Binder, Bernhard Lämmle, Walter A. Wuillemin, Irmela Sulzer, Christoph Merlo, Miha Furlan
Publikováno v:
Atherosclerosis. 161(2)
Increased levels of hemostatic factors may play a role in the pathogenesis of myocardial infarction by triggering thrombin formation. We measured factor XII (FXII), factor XI (FXI), plasma prekallikrein (PK) and high-molecular-weight kininogen (HK) i
Autor:
Contessa Edgar, Deirdra Terrell, Sara Vesely, Igor Dozmorov, Jonathoan Wren, Mark Frank, Joan Merrill, Johanna Kremer Hovinga, Judith James, James George, Amy Farris
Publikováno v:
The Journal of Immunology. 190:51.9-51.9
40% of patients who survive acute episodes of thrombotic thrombocytopenic purpura (TTP) associated with severe ADAMTS13 deficiency will relapse. Risk factors for relapse other than severe ADAMTS13 deficiency are unknown. ADAMTS13 autoantibodies, TTP
Autor:
Monica Schaller, Sabine Hiltbrunner, Irmela Sulzer, Monique Vogel, Karim Kentouche, Bernhard Laemmle, Johanna Kremer Hovinga
Publikováno v:
The Journal of Immunology. 190:68.14-68.14
A therapy aiming at neutralization of inhibitory autoantibodies (Abs) causing autoimmune thrombotic thrombocytopenic purpura (aTTP) would be highly desirable. We screened a large combinatorial small protein library of Designed-Ankryin-Repeat-Protein
Autor:
Jing-fei Dong, Roy Jefferis, Jan Voorberg, Rob Fijnheer, Ellen A. M. Turenhout, Johanna Kremer-Hovinga, Wouter Pos, Brenda M. Luken
Publikováno v:
Blood. 110:2158-2158
Acquired thrombotic thrombocytopenic purpura (TTP) is characterized by the presence of circulating antibodies directed towards ADAMTS13. This results in the formation of large platelet aggregates that occlude the microvasculature giving rise to throm